DCT

2:14-cv-06102

Supernus Pharma Inc v. Actavis Inc

General

Filed

10/01/14

Cause of ActionPatent Infringement

SectorBiotech

Status

Closed (03/16/17)

Patent Owner

NPE (L)

PACER2:14-cv-06102

CourtD. New Jersey

Judge	Period	PO Win Rate
Susan D. Wigenton	--	58%

Plaintiff

Party

Name	Ratings
Supernus Pharmaceuticals Inc NPE	L3B

Attorney

Name	Ratings
Hogan Lovells US LLP	L3B
Jared S. Schubert	---- --
Saul Ewing LLP	L3C
William C. Baton	L5A
Charles M. Lizza	L5A
Jamie L. Lucia	L4B
Sarah Ann Sullivan	L3A
Frommer Lawrence & Haug LLP	L3E
Edgar H. Haug	L5C
Laura Ann Chubb	L4E
Richard F. Kurz	L2C
Russell A. Garman	---- --
Rebecca Ann Hilgar	---- --
Haug Partners LLP	L3E
Andrew S. Roper	L4B
David A. Zwally	L4C
Sandra Kuzmich	L4C
Elizabeth Murphy	L4E

Defendant

Party

Name	Ratings
Actavis Pharma Inc	L2C
Actavis LLC	L5E
Actavis Laboratories FL Inc	L5E
Watson Laboratories Inc	L5E
Anda Inc	L5E
Allergan USA Inc	L5E
Actavis Inc	L5E

Attorney

Name	Ratings
Kirkland & Ellis LLP	L5A
Leora Ben-Ami	L5D
Nimalka R. Wickramasekera	L4A
Amanda J. Hollis	L4A
Sarah K. Tsou	L4E
Kristen L. Reichenbach	L3B
Stefan M. Miller	L3C
Winston & Strawn LLP	L5B
James F. Hurst	L5E
Merchant & Gould	L4C
Rachel C. Hughey	L5A
Christopher J. Sorenson	L5E
Bruce J. Boggs, Jr.	L5E
Aaron M. Johnson	L5E
Connell Foley LLPLocal	L3B
Liza M. Walsh	L3A
Rukhsanah L. Singh	L2A
Christine I. Gannon	L2C
Eleonore Ofosu-Antwi	L1C
Walsh Pizzi Oreilly Falanga LLPLocal	L1C
Christopher J. Borchert	L1D